MINNOVA CORP (MCI.CA) Fundamental Analysis & Valuation

TSX-V:MCI • CA6042501008

Current stock price

0.27 CAD
+0.04 (+17.39%)
Last:

This MCI.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. MCI.CA Profitability Analysis

1.1 Basic Checks

  • MCI had negative earnings in the past year.
  • In the past year MCI has reported a negative cash flow from operations.
  • In the past 5 years MCI always reported negative net income.
  • In the past 5 years MCI reported 4 times negative operating cash flow.
MCI.CA Yearly Net Income VS EBIT VS OCF VS FCFMCI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1M -2M -3M

1.2 Ratios

  • MCI's Return On Assets of -129.10% is on the low side compared to the rest of the industry. MCI is outperformed by 76.86% of its industry peers.
Industry RankSector Rank
ROA -129.1%
ROE N/A
ROIC N/A
ROA(3y)-328.85%
ROA(5y)-229.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MCI.CA Yearly ROA, ROE, ROICMCI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for MCI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MCI.CA Yearly Profit, Operating, Gross MarginsMCI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. MCI.CA Health Analysis

2.1 Basic Checks

  • MCI has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, MCI has more shares outstanding
  • Compared to 1 year ago, MCI has a worse debt to assets ratio.
MCI.CA Yearly Shares OutstandingMCI.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
MCI.CA Yearly Total Debt VS Total AssetsMCI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

2.2 Solvency

  • Based on the Altman-Z score of -15.36, we must say that MCI is in the distress zone and has some risk of bankruptcy.
  • MCI's Altman-Z score of -15.36 is on the low side compared to the rest of the industry. MCI is outperformed by 74.47% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -15.36
ROIC/WACCN/A
WACCN/A
MCI.CA Yearly LT Debt VS Equity VS FCFMCI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M

2.3 Liquidity

  • MCI has a Current Ratio of 2.28. This indicates that MCI is financially healthy and has no problem in meeting its short term obligations.
  • MCI has a Current ratio of 2.28. This is comparable to the rest of the industry: MCI outperforms 52.83% of its industry peers.
  • MCI has a Quick Ratio of 2.28. This indicates that MCI is financially healthy and has no problem in meeting its short term obligations.
  • MCI has a Quick ratio of 2.28. This is comparable to the rest of the industry: MCI outperforms 55.22% of its industry peers.
Industry RankSector Rank
Current Ratio 2.28
Quick Ratio 2.28
MCI.CA Yearly Current Assets VS Current LiabilitesMCI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. MCI.CA Growth Analysis

3.1 Past

  • MCI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -462.50%.
EPS 1Y (TTM)-462.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-913.04%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. MCI.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • MCI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MCI.CA Price Earnings VS Forward Price EarningsMCI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MCI.CA Per share dataMCI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0 0 0 0

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MCI.CA Dividend Analysis

5.1 Amount

  • No dividends for MCI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MCI.CA Fundamentals: All Metrics, Ratios and Statistics

MINNOVA CORP

TSX-V:MCI (3/31/2026, 7:00:00 PM)

0.27

+0.04 (+17.39%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)03-02
Earnings (Next)N/A
Inst Owners0.93%
Inst Owner ChangeN/A
Ins Owners12.19%
Ins Owner ChangeN/A
Market Cap33.57M
Revenue(TTM)N/A
Net Income(TTM)-3.57M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS-0.02
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -129.1%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-328.85%
ROA(5y)-229.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.28
Quick Ratio 2.28
Altman-Z -15.36
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-462.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-913.04%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-869.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-343.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-142.89%
OCF growth 3YN/A
OCF growth 5YN/A

MINNOVA CORP / MCI.CA Fundamental Analysis FAQ

What is the fundamental rating for MCI stock?

ChartMill assigns a fundamental rating of 1 / 10 to MCI.CA.


What is the valuation status of MINNOVA CORP (MCI.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to MINNOVA CORP (MCI.CA). This can be considered as Overvalued.


Can you provide the profitability details for MINNOVA CORP?

MINNOVA CORP (MCI.CA) has a profitability rating of 0 / 10.


Can you provide the financial health for MCI stock?

The financial health rating of MINNOVA CORP (MCI.CA) is 2 / 10.